Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion type Assertion NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_head.
- NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion wasGeneratedBy ECO_0000203 NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_provenance.
- NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion wasDerivedFrom befree-2016 NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_provenance.
- NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion SIO_000772 24847881 NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_provenance.
- NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion evidence source_evidence_literature NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_provenance.
- NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_provenance.